Antigen transport is the movement of soluble antigens, particulate material, microorganisms, and antigen-bearing immune cells from peripheral tissues through lymphatic vessels to draining lymph nodes, where adaptive immune responses can be initiated.
Antigen transport is the movement of antigenic material from peripheral tissues to lymphoid organs, particularly the draining lymph nodes. The lymphatic system provides the major anatomical pathway through which soluble antigens, particulate material, microorganisms, cellular debris, and antigen-bearing immune cells leave tissues and reach lymph nodes.
This transport function connects peripheral tissues with the adaptive immune system. Material entering a tissue can be collected directly by lymphatic capillaries or captured by antigen-presenting cells such as dendritic cells. Lymphatic vessels then carry these materials or cells toward regional lymph nodes, where antigens can encounter lymphocytes capable of recognizing them.
Antigen transport therefore represents an important link between tissue surveillance, lymphatic drainage, antigen presentation, and adaptive immunity.
Antigens can reach lymph nodes through several related pathways. Soluble molecules can enter lymphatic capillaries with interstitial fluid and travel in lymph, while cells that have captured antigen can actively migrate into lymphatic vessels.
A simplified pathway is:
Peripheral tissue → interstitial fluid or antigen-presenting cell → initial lymphatic vessel → collecting lymphatic vessel → afferent lymphatic vessel → draining lymph node.
Within the lymph node, antigens are distributed to specialized cellular compartments where they can be captured, processed, presented, or recognized by lymphocytes.
| Feature | Description |
|---|---|
| Origin | Peripheral tissues and organs |
| Transport pathway | Lymphatic vessels |
| Major destination | Draining lymph nodes |
| Transported material | Soluble antigens, particles, microorganisms and cellular material |
| Important transporting cells | Dendritic cells and other antigen-presenting cells |
| Node entry | Afferent lymphatic vessels |
| Major immunological function | Bringing antigen into contact with lymphocytes |
| Outcome | Immune surveillance, tolerance or activation of adaptive immune responses |
An antigen is a substance that can be specifically recognized by components of the adaptive immune system, particularly antibodies, B-cell receptors, or T-cell receptors after appropriate processing and presentation.
Antigens may originate from microorganisms, environmental substances, foreign proteins, transplanted tissues, tumor cells, or the body's own cells and molecules.
The immune consequences of antigen recognition depend on the nature of the antigen, the context in which it is encountered, and the cellular signals accompanying its presentation.
Peripheral tissues are continuously surveyed by cells of the immune system.
Dendritic cells, macrophages, and other innate immune cells can detect microorganisms, tissue damage, and foreign material. Dendritic cells are particularly important because they can capture antigen in tissues and subsequently migrate to draining lymph nodes.
This allows information about events occurring in peripheral tissues to be delivered to lymphocytes located within organized lymphoid tissue.
Soluble antigens present in interstitial fluid can enter initial lymphatic capillaries along with water, proteins, and other tissue-derived substances.
Initial lymphatic vessels have highly permeable endothelial walls adapted for uptake of interstitial material.
Once an antigen enters a lymphatic capillary, lymph flow carries it toward progressively larger collecting lymphatic vessels and regional lymph nodes.
Initial lymphatic capillaries are blind-ended vessels distributed throughout many tissues.
Their endothelial cells form specialized overlapping junctions that permit uptake of fluid and macromolecules from the interstitial space.
This structural organization allows lymphatic capillaries to collect antigenic substances that may be too large to return directly to the bloodstream through ordinary microvascular pathways.
After entering lymphatic vessels, soluble antigen is transported with lymph.
Lymph moves through collecting vessels under the influence of intrinsic lymphatic contractions, pressure gradients, skeletal muscle activity, respiration, tissue movement, and other mechanical forces.
One-way valves within collecting vessels help maintain directional movement toward regional lymph nodes.
Not all antigens travel freely in lymph. Some are transported by migrating immune cells.
Dendritic cells can capture and process antigens within peripheral tissues and then enter lymphatic vessels. These cells migrate through afferent lymphatics toward draining lymph nodes.
This cellular pathway is particularly important for presenting tissue-derived antigens to naive T lymphocytes.
Dendritic cells are specialized antigen-presenting cells that form a critical bridge between innate and adaptive immunity.
In peripheral tissues, they sample their environment and capture antigen. Following appropriate activation or maturation signals, dendritic cells increase their capacity to migrate and present antigen to T cells.
They then travel through lymphatic vessels to regional lymph nodes.
Migration of dendritic cells from tissues to lymph nodes is an active, regulated process.
After antigen capture and activation, dendritic cells alter their expression of chemokine receptors and become responsive to signals produced by lymphatic endothelial cells and lymphoid tissues.
This guides the cells toward lymphatic vessels and ultimately toward the T-cell regions of draining lymph nodes.
The chemokine receptor CCR7 plays an important role in the migration of activated dendritic cells toward lymphatic vessels and lymph nodes.
CCR7 responds to chemokines including CCL19 and CCL21. These signals help direct dendritic cells through lymphatic pathways and toward appropriate regions within lymph nodes.
CCR7-mediated migration is therefore an important molecular mechanism connecting peripheral antigen capture with lymph-node antigen presentation.
Afferent lymphatic vessels carry lymph toward lymph nodes.
They deliver soluble antigens, particulate material, immune cells, and other tissue-derived substances to the node.
Multiple afferent vessels can enter the convex surface of a lymph node, allowing the node to receive material from a defined anatomical drainage territory.
Afferent lymphatic vessels enter the outer surface of the lymph node and release lymph into the subcapsular sinus.
From this region, lymph and its contents can move through the sinus system of the node while antigens interact with macrophages, dendritic cells, B cells, and other immune components.
Migrating dendritic cells can move from lymphatic sinuses into the lymph-node parenchyma and localize within T-cell-rich regions.
The subcapsular sinus lies immediately beneath the fibrous capsule of a lymph node and receives lymph directly from afferent lymphatic vessels.
It represents an important initial site of contact between lymph-borne material and immune cells within the node.
Specialized macrophages associated with this region can capture particulate antigens and microorganisms arriving in lymph.
Lymph passes from the subcapsular sinus through interconnected cortical and medullary sinus pathways before leaving the node.
These sinuses expose lymph-borne material to resident immune cells and contribute to filtration of particles and microorganisms.
The architecture of the lymph node therefore combines fluid transport with immune surveillance.
Different forms of antigen can follow different pathways after reaching a lymph node.
Small soluble antigens may move through specialized conduits within the node, while larger particles may remain associated with sinus regions or be captured by macrophages and other antigen-presenting cells.
Antigen-bearing dendritic cells migrate into the paracortical region, where large numbers of T lymphocytes circulate and survey presented antigens.
The lymph node contains a network of specialized extracellular matrix channels known as the conduit system.
This system can transport small soluble molecules from lymphatic sinuses into deeper portions of the lymph node.
It allows selected lymph-borne molecules to reach immune cells without requiring bulk lymph to flow freely through the entire lymph-node parenchyma.
Antigen presentation is the process by which antigen-derived peptides are displayed to T lymphocytes by major histocompatibility complex molecules.
Professional antigen-presenting cells, particularly dendritic cells, capture proteins, process them into peptide fragments, and display these peptides on their surfaces.
Naive T cells circulating through lymph nodes can then examine these peptide-MHC complexes.
MHC class I molecules present peptides primarily to CD8-positive T lymphocytes.
These molecules are expressed by nearly all nucleated cells, although specialized dendritic cells are particularly important for activating naive CD8 T cells.
Dendritic cells can also use cross-presentation pathways to present certain extracellular antigens on MHC class I molecules.
MHC class II molecules present peptide antigens primarily to CD4-positive T lymphocytes.
They are expressed predominantly by professional antigen-presenting cells such as dendritic cells, macrophages, and B lymphocytes.
Antigens captured from extracellular environments can be processed within intracellular vesicles and presented through the MHC class II pathway.
The paracortex of a lymph node is rich in T lymphocytes and dendritic cells.
Antigen-bearing dendritic cells arriving from peripheral tissues migrate into this region.
Naive T cells entering the lymph node can interact with numerous dendritic cells, increasing the probability that rare antigen-specific lymphocytes will encounter their corresponding antigen.
B lymphocytes are concentrated within lymphoid follicles of the superficial cortex.
B cells can recognize intact antigens through their surface immunoglobulin receptors rather than requiring peptide presentation in the same manner as T cells.
Lymph-borne antigens can reach B-cell areas through several pathways involving lymphatic sinuses, antigen-carrying cells, and specialized stromal and immune-cell networks.
Subcapsular sinus macrophages are strategically positioned to encounter material entering lymph nodes through afferent lymphatics.
They can capture particulate antigens, immune complexes, and microorganisms from lymph.
Captured antigen may subsequently become available to other immune cells, including B lymphocytes.
Follicular dendritic cells are specialized stromal cells found within B-cell follicles and germinal centers.
They can retain intact antigen, particularly in the form of immune complexes, on their surfaces for prolonged periods.
This retained antigen contributes to B-cell selection and affinity maturation during germinal-center responses.
Efficient antigen transport works together with lymphocyte recirculation.
Rather than requiring antigen-specific lymphocytes to be present at the original site of infection, the immune system brings tissue-derived antigens to organized lymphoid organs while naive lymphocytes continuously circulate through those organs.
This arrangement greatly increases the probability that antigen-specific lymphocytes will encounter their target antigen.
Many naive lymphocytes enter lymph nodes from the bloodstream through specialized postcapillary venules called high endothelial venules.
After entering the node, lymphocytes migrate through T-cell and B-cell regions while surveying antigen-presenting cells and other sources of antigen.
Lymphocytes that do not encounter their antigen eventually leave and continue recirculating.
When a naive T lymphocyte recognizes its specific peptide-MHC complex on an appropriately activated antigen-presenting cell and receives the required additional signals, it can become activated.
Activated T cells undergo clonal expansion and differentiation into effector and memory populations.
These cells can subsequently leave the lymph node and participate in immune responses elsewhere in the body.
B lymphocytes can bind specific intact antigens through their B-cell receptors.
Following appropriate activation signals, antigen-specific B cells proliferate and differentiate. Some become antibody-secreting plasma cells, while others become memory B cells.
Many antibody responses also involve interactions between antigen-specific B cells and helper T cells.
Lymphatic drainage is organized anatomically. Particular tissues generally drain toward defined groups of regional lymph nodes.
As a result, antigens originating from a particular anatomical region tend to reach predictable draining lymph nodes.
This relationship is important both for normal immune responses and for understanding the spread of infections and malignant cells.
A draining lymph node is a lymph node that receives lymph from a particular tissue or anatomical region.
When infection, inflammation, vaccination, or tissue injury occurs, antigens and antigen-presenting cells from the affected area are transported toward these nodes.
Immune activation within draining nodes can cause them to enlarge as lymphocytes proliferate and immune-cell activity increases.
During infection, microbial antigens and inflammatory signals accumulate within affected tissues.
Soluble microbial products can enter lymphatic vessels directly, while dendritic cells capture microbial material and migrate toward regional lymph nodes.
This allows adaptive immune responses to begin in organized lymphoid tissue even when the infection itself remains localized in a peripheral tissue.
Vaccines introduced into peripheral tissues rely in part on lymphatic drainage and antigen-presenting cell migration.
Vaccine antigens and associated immune-stimulating signals can reach draining lymph nodes through lymphatic pathways.
Within these nodes, antigen-specific T and B lymphocytes can be activated and expanded, contributing to development of immunological memory.
Transport of antigen to lymph nodes does not always produce an inflammatory immune response.
Peripheral self-antigens and harmless environmental antigens can also reach lymphoid tissues.
Depending on the antigen, antigen-presenting cell state, costimulatory signals, cytokine environment, and other factors, antigen recognition can contribute to immune tolerance rather than activation.
After lymph has passed through a lymph node, it leaves through efferent lymphatic vessels at the hilum.
Efferent lymph contains lymphocytes, antibodies, soluble molecules, and material that has passed through the node.
It can then enter additional lymph nodes or larger lymphatic trunks before ultimately returning to the venous circulation.
| Feature | Soluble Antigen Transport | Cell-Mediated Transport |
|---|---|---|
| Transported material | Free soluble antigen and small molecules | Antigen carried or processed by migrating cells |
| Major carrier | Lymph | Dendritic cells and other migrating immune cells |
| Entry pathway | Initial lymphatic capillaries | Active migration into lymphatic vessels |
| Destination | Lymph-node sinuses and internal antigen-distribution pathways | Primarily lymph-node immune-cell regions |
| Major role | Rapid delivery of tissue-derived material | Antigen presentation, especially to T cells |
Lymphadenopathy refers to enlargement or abnormality of lymph nodes.
During infection or inflammation, increased delivery of antigen and immune cells to draining lymph nodes can stimulate lymphocyte proliferation and other immune responses, causing regional nodes to enlarge.
The location of enlarged nodes can provide information about the anatomical territory in which an inflammatory or infectious process may be occurring.
Lymphangitis is inflammation involving lymphatic vessels, commonly in association with infection.
Microorganisms and inflammatory material can enter lymphatic vessels and travel toward regional lymph nodes.
Inflammation along superficial lymphatic pathways can sometimes produce visible linear erythema extending toward the draining nodal region.
Lymphadenitis is inflammation of lymph nodes, often associated with infection in their drainage territory.
Antigenic material and microorganisms transported through afferent lymphatics can stimulate strong local immune responses within the node.
Affected nodes may become enlarged and tender.
A sentinel lymph node is the first lymph node, or one of the first nodes, expected to receive lymphatic drainage from a particular anatomical region or lesion.
The concept is clinically important because lymphatic transport pathways can also carry malignant cells from primary tumors.
Sentinel lymph node mapping is therefore used in selected cancers to assess regional lymphatic spread.
Tumors release antigens and cellular material into their surrounding tissues.
Tumor-derived antigens can reach draining lymph nodes through soluble lymphatic transport or through antigen-presenting cells that have captured tumor material.
These pathways can contribute to immune recognition of tumors, although tumors may also develop mechanisms that suppress or evade effective immune responses.
Malignant cells can enter lymphatic capillaries and travel through lymphatic vessels toward regional lymph nodes.
This process is anatomically related to normal lymphatic transport but involves movement of viable tumor cells rather than simply antigenic material.
Knowledge of regional lymphatic drainage is therefore important in cancer staging and surgical oncology.
Obstruction or disruption of lymphatic vessels can alter the movement of tissue-derived antigens and antigen-presenting cells toward lymph nodes.
Damage may result from surgery, radiation, malignancy, infection, trauma, or congenital abnormalities.
The immunological consequences depend on the extent of disruption and the ability of collateral lymphatic pathways to compensate.
The effectiveness of many vaccines depends on successful delivery of antigen and immune-stimulating signals to lymphoid tissues.
Lymphatic transport brings vaccine-derived material and activated antigen-presenting cells into contact with populations of naive lymphocytes.
This contributes to clonal expansion and development of antigen-specific effector and memory cells.
Antigen transport allows the immune system to monitor large areas of peripheral tissue without requiring every naive lymphocyte to continuously patrol every tissue directly.
Instead, the lymphatic system collects tissue-derived material and antigen-bearing cells and directs them toward strategically organized lymph nodes. At the same time, lymphocytes continually recirculate through these lymphoid organs.
This organization brings antigens, antigen-presenting cells, and antigen-specific lymphocytes together efficiently, making lymphatic antigen transport a fundamental component of immune surveillance and adaptive immunity.